July 30, 2024
Data sharing as the foundation of discovery: ADNI and breakthroughs in Alzheimer’s disease
Alzheimer's & Dementia
May 1, 2024
Accelerating Medicines Partnership Bespoke Gene Therapy Consortium for Rare Disorders
Nippon Rynsho
April 15, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clinical Cancer Research
American Association for Cancer Research Journal
April 5, 2024
Messiah or pariah? Psychosis, science, and finding meaning in lived experience
Nature
April 3, 2024
Financing Our Future In The Pandemic Agreement And International Health Regulations
Health Affairs Forefront
March 7, 2024
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Schizophrenia Bulletin
February 28, 2024
Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial
Journal of the American Heart Association
January 8, 2024
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
Cancer Cell
Show More
banner

Partner With Us

Work with the FNIH to accelerate medical breakthroughs for patients